Resources for observational comparative research have expanded enormously in recent years to include very large sources of ...
The TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) demonstrated a statistically significant ...
If CMS cannot persuade GRAIL of the importance of randomization and using cancer death as the outcome, then it should cancel the study. The magnitude of the problem was evident in a major National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results